Your browser doesn't support javascript.
loading
Multivariate prediction of dementia in Parkinson's disease.
Phongpreecha, Thanaphong; Cholerton, Brenna; Mata, Ignacio F; Zabetian, Cyrus P; Poston, Kathleen L; Aghaeepour, Nima; Tian, Lu; Quinn, Joseph F; Chung, Kathryn A; Hiller, Amie L; Hu, Shu-Ching; Edwards, Karen L; Montine, Thomas J.
Affiliation
  • Phongpreecha T; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA USA.
  • Cholerton B; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA USA.
  • Mata IF; Department of Biomedical Data Science, Stanford University School of Medicine, Palo Alto, CA USA.
  • Zabetian CP; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA USA.
  • Poston KL; Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH USA.
  • Aghaeepour N; Veterans Affairs Puget Sound Health Care System, Seattle, WA USA.
  • Tian L; Department of Neurology, University of Washington School of Medicine, Seattle, WA USA.
  • Quinn JF; Department of Neurology and Neurological Sciences, Stanford School of Medicine, Palo Alto, CA USA.
  • Chung KA; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA USA.
  • Hiller AL; Department of Biomedical Data Science, Stanford University School of Medicine, Palo Alto, CA USA.
  • Hu SC; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA USA.
  • Edwards KL; Department of Biomedical Data Science, Stanford University School of Medicine, Palo Alto, CA USA.
  • Montine TJ; Portland Veterans Affairs Health Care System, Portland, OR USA.
NPJ Parkinsons Dis ; 6: 20, 2020.
Article in En | MEDLINE | ID: mdl-32885039
Cognitive impairment in Parkinson's disease (PD) is pervasive with potentially devastating effects. Identification of those at risk for cognitive decline is vital to identify and implement appropriate interventions. Robust multivariate approaches, including fixed-effect, mixed-effect, and multitask learning models, were used to study associations between biological, clinical, and cognitive factors and for predicting cognitive status longitudinally in a well-characterized prevalent PD cohort (n = 827). Age, disease duration, sex, and GBA status were the primary biological factors associated with cognitive status and progression to dementia. Specific cognitive tests were better predictors of subsequent cognitive status for cognitively unimpaired and dementia groups. However, these models could not accurately predict future mild cognitive impairment (PD-MCI). Data collected from a large PD cohort thus revealed the primary biological and cognitive factors associated with dementia, and provide clinicians with data to aid in the identification of risk for dementia. Sex differences and their potential relationship to genetic status are also discussed.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: NPJ Parkinsons Dis Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: NPJ Parkinsons Dis Year: 2020 Type: Article